Aug 2026· Advances in Integrated Healthcare Research· Vol 1, pp. 41-55· 0 citations· 23 references
TL;DR
Wearable technologies were associated with increased physical activity and showed potential for scalable atrial fibrillation detection and can play a positive role in reinforcing preventative care, when used within a clinically driven care pathway.
Abstract
Background: Wearable technologies can continuously capture physiological and behavioral data and are becoming more capable of being applied to preventive health care. They may enable the ability for risk factor modification, early detection, longitudinal risk stratification, and alerts for deterioration when integrated to clinical pathways. Methods: The methods used in this narrative review were to conduct a search of the literature to identify relevant clinical applications of wearables in preventive health and to summarize them. The following types of studies were taken into account: reviews and clinical trials, validation studies and cohort studies. Evidence was classified based on its preventive function and clinical effectiveness, validity of measurement, and requirements for implementation. Results: Wearable technologies were associated with increased physical activity and showed potential for scalable atrial fibrillation detection. Cuffless blood pressure, metabolic prevention, sleep monitoring and circadian rhythms, fall-risk, and infection monitoring also showed promising potential. However, the evidence was of limited quality due to the low accuracy, sensitivity and specificity of tests; limited durations of follow-up and limited implementation into clinical workflows. Increased clinical benefit was found when wearable derived data were validated and fed into professional decision making. Conclusions: Wearables can play a positive role in reinforcing preventative care, when used within a clinically driven care pathway. Outcome based trials, interoperability, health equity, data minimization and continued clinical engagement should be the focus of future studies.
Cardiovascular diseases remain the leading cause of global mortality, yet conventional diagnostics are episodic and clinic-centered, missing the dynamic physiological events that unfold between encounters. Wearable devices offer continuous, real-world monitoring and, together with artificial intelligence, digital bioma...
Simona Steliana Tudor, Ancuța Elena Țupu, A. Munteanu et al.· Healthcare· 0 citations
This narrative socio-medical review examines how wearable health technologies contribute to the medicalization of everyday life by transforming ordinary activities into quantifiable indicators classified as normal, suboptimal, or potentially requiring intervention.
M. Sierant, Malwina Kwaśniewska, Kamila Zmysłowska et al.· International Journal of Inn...· 0 citations
Wearable devices show promise as objective anchors to drive provider-patient interactions in cardiometabolic lifestyle interventions; offering scalable, valid measurement tools to quantify sleep health and inform cardiovascular risk assessment.
M. Amadei, D. Reichenberger, Dorothy Tung et al.· Arteriosclerosis, Thrombosis...· 0 citations
Wearable biosensors have considerable potential to improve early intervention, lessen healthcare costs, and facilitate remote care models, but additional clinical validation, regulatory alignment, and strong integration into healthcare infrastructures are necessary to realise this potential.
W. Badru, H. Afolabi, R. Elesho et al.· Elicit Journal of Medical Sc...· 0 citations
Wearable technologies are increasingly used to support cardiovascular care by enabling continuous physiological monitoring beyond conventional clinical environments. Advances in consumer and medical-grade devices have expanded cardiovascular surveillance from intermittent assessments to longitudinal monitoring of heart...
A. Tariq, Wonbum Sohn, Yoon Jae Lee et al.· Arteriosclerosis, Thrombosis...· 0 citations
Wearable and connected devices should be treated as components of an organized self-management system rather than stand-alone therapies, and future implementation should prioritize validated measurement, low-burden design, human support, interoperability, and equity-sensitive evaluation over device novelty.
Radosław Sciepuro, Marta Czarnowska, Nina Czarnowska· International Journal of Inn...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.